Q1FY27 saw robust revenue and EBITDA growth, with margin expansion and the strongest Q1 net income in three years. Specialty chemicals and Advanta segments led performance, while net debt rose due to seasonal working capital. FY27 guidance targets 7–11% revenue growth and 10–14% EBITDA growth.

Original document:

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.